Non-opioids Solutions for Cancer Treatment and Pain Management

USD 950

* Required Fields

USD 950


Be the first to review this product

Marine-derived pharmaceuticals have been used as sources of providing a range of chemical diversity in drug discovery. Marine-derived pharmaceuticals are the outcome of a breakthrough application of biotechnology. They enable producing therapeutic agents that could ultimately be used by the medical community to combat life-threatening illnesses. The sudden increase in the utilization of marine-derived pharmaceutical products can be directly linked to the uptake of research activities in this space. These marine derived pharmaceutical products require a significant amount of basic and applied research, so that they can be compared in terms of efficacy and safety and quality to patented pharmaceutical products that are in the market.

The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.

The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Marine-derived pharmaceuticals, chemical diversity, marine biotechnology, pharmaceutical potential, marine organism

Table of Contents

Non-opioids Solutions for Cancer Treatment and Pain ManagementInnovations in Non-opioids TherapeuticsInspired by the Sea to Discover Molecules with Antitumor ActivityMarine-based Compound Library Generation and Drug DiscoveryUnparalleled Chemical Diversity in High Impact TherapeuticsMarine Microbial Product for Fighting Tumor MicroenvironmentNon-addictive Drug Composition for Severe Pain TreatmentNovel Antibody Drug Conjugate to Limit Tumor GrowthIntrathecal Infusion for Severe Pain Minus the Bothersome Side-effectsMarine Pharmaceuticals Pipeline Analysis and Industry InteractionsPipeline AnalysisPipeline Analysis (Continued) Pipeline Analysis (Continued)Industry InteractionsIndustry Interactions (Continued)




Related Research

Release Date : 15-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 01-Dec-17

Region : Global

Release Date : 29-Nov-17

Region : Global

Related Subscription

• One-2-One Analyst briefing call •
• Access to published and new research deliverables •
• Mid year service review •
• Virtual Analyst briefing •
• GIL conference seats •

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.